Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

 Oxytrol (Oxybutynin) Transdermal System
Company:  Watson Laboratories, Inc.
Application No.:  021351
Approval Date: 2/26/2003

 

Date created: April 082005

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-